|
Volumn 19, Issue 18, 2011, Pages 5334-5341
|
5a-Carba-β-d-glucopyranose derivatives as novel sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes
|
Author keywords
5a Carba d glucopyranose; Carbasugar; Metabolic stabilization; SGLT2 inhibitor; Type 2 diabetes
|
Indexed keywords
(2 BENZYLPHENYL) 5A CARBA BETA DEXTRO GLUCOPYRANOSIDE;
1 BENZYLOXY 2 (4 CYCLOPROPYLBENZYL)BENZENE;
2 (2,3,4,6 TETRA O BENZYL 5A CARBA BETA DEXTRO GLUCOPYRANOSYL)BENZALDEHYDE;
2 (2,3,4,6 TETRA O BENZYL 5A CARBA BETA DEXTRO GLUCOPYRANOSYL)BENZOIC METHYL ESTER;
2 (2,3,4,6 TETRA O BENZYL 5A CARBA BETA DEXTRO GLUCOPYRANOSYL)BENZYL ALCOHOL;
2 (4 BROMOBENZYL)PHENOL;
2 (4 CHLOROBENZYL)PHENOL;
2 (4 CYCLOPROPYLBENZYL)PHENOL;
2 (4 ETHOXYBENZYL)PHENOL;
2 (4 FLUOROBENZYL)PHENOL;
2 (4 ISOPROPYLBENZYL)PHENOL;
2 (4 METHYLSULFANYLBENZYL)PHENOL;
2 (4 TRIFLUOROMETHYLBENZYL)PHENOL;
2 BENZYLOXYPHENYL (4 CYCLOPROPYLBENZYL)METHANOL;
2,3,4 TRISBENZYLOXY (5 BENZYLOXYMETHYL)CYCLOHEXYL TRIFLUOROMETHANESULFONATE;
2,3,4,6 TETRA O BENZYL 5A CARBA ALPHA DEXTRO GLUCOPYRANOSE;
5A CARBA BETA DEXTRO GLUCOPYRANOSE DERIVATIVE;
[2 (2,3,4,6 TETRA O BENZYL 5A CARBA BETA DEXTRO GLUCOPYRANOSYL)PHENYL] 4 METHOXYPHENYLMETHANOL;
[2 (4 ETHOXYBENZYL)PHENYL] 5A CARBA BETA DEXTRO GLUCOPYRANOSIDE;
[2 (4 ETHYLBENZYL)PHENYL] 5A CARBA BETA DEXTRO GLUCOPYRANOSIDE;
[2 (4 ISOPROPYLBENZYL)PHENYL] 5A CARBA BETA DEXTRO GLUCOPYRANOSIDE;
[2 (4 METHOXYBENZYL)PHENYL] 5A CARBA BETA DEXTRO GLUCOPYRANOSIDE;
[2 (4 METHYLBENZYL)PHENYL] 5A CARBA BETA DEXTRO GLUCOPYRANOSIDE;
[2 (4 NPROPYLBENZYL)PHENYL] 5A CARBA BETA DEXTRO GLUCOPYRANOSIDE;
[2 (4 VINYLBENZYL)PHENYL] 5A CARBA BETA DEXTRO GLUCOPYRANOSIDE;
AGLYCONE;
ANTIDIABETIC AGENT;
SERGLIFLOZIN ETABONATE;
SODIUM GLUCOSE COTRANSPORTER 2;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CARBON NUCLEAR MAGNETIC RESONANCE;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG POTENCY;
DRUG SELECTIVITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME INHIBITION;
GLUCOSE BLOOD LEVEL;
LIPOPHILICITY;
MALE;
MOUSE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
NUCLEOTIDE SEQUENCE;
PROTON NUCLEAR MAGNETIC RESONANCE;
SINGLE DRUG DOSE;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
DIABETES MELLITUS, EXPERIMENTAL;
DIABETES MELLITUS, TYPE 2;
GLUCOSE;
MALE;
MICE;
MICE, OBESE;
MOLECULAR CONFORMATION;
MOLECULAR SEQUENCE DATA;
SODIUM-GLUCOSE TRANSPORTER 2;
STEREOISOMERISM;
STRUCTURE-ACTIVITY RELATIONSHIP;
TISSUE DISTRIBUTION;
MUS;
|
EID: 80052572117
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2011.08.005 Document Type: Article |
Times cited : (19)
|
References (22)
|